CHA 2 DS 2 -VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban
Author:
Publisher
Elsevier BV
Subject
Emergency Medicine
Reference36 articles.
1. Stroke risk stratification scores in atrial fibrillation. Current recommendations for clinical practice and future perspectives;Durrant;Expert Rev Cardiovasc Ther,2013
2. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis;Marinigh;J Am Coll Cardiol,2010
3. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study;Go;JAMA,2001
4. Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke;Kaarisalo;Stroke,1997
5. Bleeding risk assessment and management in atrial fibrillation patients. A position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis;Lip;Europace,2011
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of the Inappropriate Prescribing Practices of Rivaroxaban and Their Association with Bleeding in Tertiary Care Hospitals in Saudi Arabia;Saudi Journal of Clinical Pharmacy;2023-04
2. Evaluation of the inappropriate prescribing practices of rivaroxaban and their association with bleeding in tertiary care hospitals in Saudi Arabia;Saudi Journal of Clinical Pharmacy;2023
3. Prophylactic Left Atrial Appendage Exclusion in Cardiac Surgery Patients With Elevated CHA2DS2-VASc Score: Results of the Randomized ATLAS Trial;Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery;2022-11
4. Comparative analysis of left atrial appendage closure efficacy and outcomes by CHA2DS2-VASc score group in patients with non-valvular atrial fibrillation;Frontiers in Cardiovascular Medicine;2022-07-22
5. When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics;Vascular Health and Risk Management;2019-09
When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3